JPM Thematics - Genetic Therapies C2 Fonds
90,77
EUR
+1,37
EUR
+1,53
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Amgen Inc | US0311621009 | 3,51% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,49% |
| Novartis AG Registered Shares | CH0012005267 | 3,31% |
| Ionis Pharmaceuticals Inc | US4622221004 | 3,26% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,06% |
| CRISPR Therapeutics AG | CH0334081137 | 3,03% |
| Sarepta Therapeutics Inc | US8036071004 | 3,02% |
| Gilead Sciences Inc | US3755581036 | 3,01% |
| Roche Holding AG | CH0012032048 | 2,94% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,90% |
| Sonstige | 68,46% |